 Credit Suisse analyst John Walsh lowered Xylem Incs NYSE:XYL price target from 110 to 105, implying a downside of 13, and maintained an Underperform rating. RBC Capital analyst Deane Dray lowered the price target to 136 implying an upside of 12 from 140 and maintained an Outperform rating on the shares. 